Implantable cardioverter defibrillator therapy is cost effective for primary prevention patients in Taiwan: An analysis from the Improve SCA trial

• Reece Holbrook,

  Roles Conceptualization, Formal analysis, Methodology, Writing – original draft

  Affiliation Medtronic, plc, Dublin, Ireland

  https://orcid.org/0000-0001-8995-3024

  ⨯
• Lucas Higuera,

  Roles Validation, Writing – review & editing

  Affiliation Medtronic, plc, Dublin, Ireland

  ⨯
• Kael Wherry,

  Roles Validation, Writing – review & editing

  Affiliation Medtronic, plc, Dublin, Ireland

  ⨯
• Dave Phay,

  Roles Conceptualization, Data curation, Writing – review & editing

  Affiliation Medtronic, plc, Dublin, Ireland

  ⨯
• Yu-Cheng Hsieh,

  Roles Conceptualization, Supervision, Writing – review & editing

  Affiliation Department of Cardiology, Taichung Veterans General Hospital and National Yan-Ming University School of Medicine, Taichung, Taiwan

  ⨯
• Kuo-Hung Lin,

  Roles Conceptualization, Supervision, Writing – review & editing

  Affiliation Department of Cardiology, China Medical Center University Hospital

  ⨯
• Yen-Bin Liu

  Roles Conceptualization, Supervision, Writing – review & editing

  * E-mail: yenbin@ntu.edu.tw

  Affiliation Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan

  https://orcid.org/0000-0003-0623-9146

  ⨯